BOUNDLESS BIO INC

Kevin Tang’s Steady Buy‑Back of 3 M Shares Signals Confidence in Boundless Bio’s Oncology Platform.

Kevin Tang’s fresh buy of Boundless Bio shares signals confidence in its ecDNA oncology platform, hinting at a rebound ahead of Phase‑1/2 data.

BOUNDLESS BIO INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

22/07/2026, 01:54

3 minutes to read

Kevin Tang’s Surge: Insider Buying Spree Signals Optimism for Boundless Bio’s Next Big Breakthrough

Inside Boundless Bio: Kevin Tang’s fresh 100k‑share buy signals optimism on ecDNA‑cancer therapy, partnership and leadership moves that could drive future upside.

BOUNDLESS BIO INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/07/2026, 02:01

3 minutes to read